ENTITY
Sino Biopharmaceutical

Sino Biopharmaceutical (1177 HK)

197
Analysis
Health CareHong Kong
Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.
more
01 Sep 2024 10:05

Hong Kong Connect Flows (Aug 30th): Tencent, Xiaomi Corporation

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Tencent (700 HK), Xiaomi Corporation (1810 HK).

Logo
318 Views
Share
25 Aug 2024 10:05

Hong Kong Connect Flows (Aug 23rd): Tencent, China Mobile

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Tencent (700 HK), China Mobile (941 HK).

Logo
304 Views
Share
bullishTencent
18 Aug 2024 20:43

Hang Seng Index Sep24 Rebal - No Name Changes, Some Capping, 1% One-Way Flow - Total 0️⃣🍔

The HSI committee promised changes to rebalance towards better sector representation and a move to 100 names. That was a couple years ago. Progress...

Logo
379 Views
Share
18 Aug 2024 20:43

HSCEI Sep24 Rebal - Two ADDs, Two DELETEs, Two Surprises, Middling Flows

HSCEI sees two ADDs and two DELETEs, as expected, but one of the ADDs was unexpected, and the main expected ADD was n-o-t added. This will surprise...

Logo
367 Views
Share
18 Aug 2024 10:05

Hong Kong Connect Flows (Aug 16th): Tencent, China Mobile

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Tencent (700 HK) , China Mobile (941 HK) .

Logo
244 Views
Share
x